Business Context and Reporting Period
Company: Wound Management Technologies, Inc. (WMT)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010
Business Overview: WMT focuses on advanced wound care products (CellerateRX), orthopedic solutions (resorbable bone wax), and healthcare technology (Cifra platform). The company operates through subsidiaries including Wound Care Innovations, LLC, BioPharma Management Technologies, Inc., and Secure eHealth, LLC. The filing includes a "Going Concern" warning due to limited operations and reliance on debt/equity issuance to fund expenses.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Revenues | $66,690 | $53,428 |
| Cost of Revenue | $20,397 | $310,145 |
| Gross Profit | $46,293 | $(256,717) |
| Net Loss | $(1,244,507) | $(509,257) |
| Loss Per Share (Basic/Diluted) | $(0.04) | $(0.02) |
| Cash and Equivalents (End of Period) | $2,552 | $104,539 |
| Total Current Assets | $249,046 | $156,308 |
| Total Current Liabilities | $3,582,208 | $2,457,610 |
| Stockholders' Equity | $2,633,320 | $2,314,987 |
Debt Profile: Total Notes Payable (related parties) increased to $1,850,980. The company holds a $1,500,000 Senior Secured Convertible Promissory Note Receivable acquired in February 2010.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 25% to $66,690, driven by expanded domestic and international awareness.
- Cost Reduction: Cost of revenue decreased 93% to $20,397. The prior year included a one-time payment to a patent holder.
- Expense Increase: General and Administrative (G&A) expenses rose 85% to $387,843, primarily due to increased consulting fees.
- Net Loss Expansion: Net loss increased 144% to $1.24 million. This was significantly driven by a $720,657 loss on debt settlement recognized in Q1 2010.
- Interest Activity: Interest income surged 3,844% due to the acquisition of a note receivable from VHGI Holdings. Interest expense increased 140% due to higher debt levels.
- Acquisitions: On February 1, 2010, the company acquired assets and liabilities from VHGI Holdings, Inc. for $500,000 (cash and note), including a $1.5M note receivable.
Outlook, Risks, and Contingencies
- Going Concern: The company has current liabilities exceeding current assets and has not established a reliable revenue source. Continuation depends on obtaining additional funding.
- Liquidity Needs: Management states additional capital is required in fiscal year 2010 to fund operations. There is no assurance that capital raising efforts will succeed.
- Tax Liabilities: The company is delinquent on 2004-2005 federal payroll taxes. As of March 31, 2010, unpaid taxes totaled approximately $203,484 with penalties and interest of $188,882. A tax lien was filed in December 2009.
- Legal Proceedings: WMT is a defendant in a Florida state court lawsuit regarding alleged nonpayment of brokerage commissions. Management considers the claim without merit.
- Subsequent Events:
- Issued $255,000 in convertible debentures on April 1, 2010.
- Entered a subscription agreement on May 14, 2010, to sell 250,000 units (stock + warrants) at $0.40/unit; proceeds not yet received.
Investor Verification Checklist
- Cash Position: Verify the extremely low cash balance ($2,552) against the high level of current liabilities ($3.58M) to assess immediate solvency risk.
- Debt Settlement: Confirm the details of the $720,657 loss on debt settlement and the terms of the stock issued to settle this debt.
- IRS Status: Investigate the status of negotiations regarding the $392,366 total tax liability (principal + penalties) and the existing tax lien.
- Related Party Transactions: Review the $1.85M in notes payable to related parties (including the CEO's entities) and the terms of the $1.5M note receivable acquired from a related entity (VHGI).
- Revenue Sustainability: Assess whether the 25% revenue increase is sustainable given the heavy reliance on one-time cost reductions in the prior year and the lack of recurring revenue streams.